Xylem Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Xylem Inc. on February 24, 2023, covering events occurring on March 1, 2023, and February 24, 2023. The filing details the entry into a new material definitive credit agreement, the termination of a prior credit facility, and the appointment of a new director.
Key Financial Metrics and Agreements
- New Credit Facility: Entered into a Five-Year Revolving Credit Facility on March 1, 2023, with an aggregate principal amount of up to $1,000,000,000.
- Expansion Option: The facility allows for increases of up to $300,000,000, bringing the maximum aggregate principal amount to $1,300,000,000.
- Outstanding Borrowings: No borrowings were outstanding under the new agreement as of the filing date.
- Interest Structure: Borrowings accrue interest based on a base rate or Adjusted Term SOFR/EURIBOR plus an applicable margin determined by a pricing grid linked to the Company's credit rating and a Sustainability Spread Adjustment.
- Covenants: The agreement requires the maintenance of a consolidated total debt to consolidated EBITDA ratio based on the last four fiscal quarters.
Material Changes Versus Prior Period
The Company terminated its previous Five-Year Revolving Credit Facility Agreement dated March 5, 2019 (the "2019 Credit Agreement"). The 2019 facility provided for a senior unsecured revolving credit facility of $800,000,000, with an option to increase up to $1,000,000,000. The new 2023 agreement replaces this facility with a larger initial commitment and higher expansion capacity.
Management Commentary, Governance, and Risks
- Board Appointment: On February 24, 2023, the Board of Directors increased its size from 10 to 11 members and appointed Earl R. Ellis as a director, effective March 9, 2023. Mr. Ellis is currently the Executive Vice President and Chief Financial Officer at ABM Industries Incorporated.
- Compensation: Mr. Ellis will receive compensation consistent with standard arrangements for non-employee directors, prorated for the current term.
- Usage of Funds: Proceeds from the new credit facility are designated for working capital and other general corporate purposes.
- Risks and Covenants: The agreement includes customary covenants limiting secured debt, liens, sale and lease-back transactions, mergers, and asset sales. It also contains standard events of default.
Investor Verification Checklist
- Verify the specific terms of the pricing grid and Sustainability Spread Adjustment in the attached Exhibit 10.1 (2023 Credit Agreement).
- Confirm the Company's current consolidated total debt to consolidated EBITDA ratio to ensure compliance with the new covenant.
- Review the 2022 Proxy Statement for details on the standard compensatory arrangements for non-employee directors.
- Monitor future press releases or filings for the utilization of the new credit facility and any changes to the Board's committee assignments for the new director.